WHO set to resume hydroxychloroquine trial in battle with COVID-19

The World Health Organization (WHO) is set to resume its trial of hydroxychloroquine for potential use against the new coronavirus, its head said on Wednesday, after testing was suspended due to health concerns.

The U.N. body had paused its large study of the anti-malarial drug to treat COVID-19 due to fears it increased death rates and irregular heartbeats in patients. Speaking alongside the head of WHO, the WHO epidemiologist warned that the virus could become more dangerous if people became complacent, but added that the virus itself was stable and wasn't mutating in a way that would make it more severe.